Synonyms: A-195773 | Abbott-195773 | ABT-773 | ABT773 | Restanza®
Compound class:
Synthetic organic
Comment: Cethromycin is an orally bioavailable ketolide antibacterial that is structurally related to erythromycin. It was developed by Abbott Laboratories for potential to treat respiratory infections, including community acquired pneumonia (CAP) and for the prevention of post-exposure inhalational anthrax [1-2].
|
|
References |
1. Hammerschlag MR, Sharma R. (2008)
Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections. Expert Opin Investig Drugs, 17 (3): 387-400. [PMID:18321237] |
2. Rafie S, MacDougall C, James CL. (2010)
Cethromycin: a promising new ketolide antibiotic for respiratory infections. Pharmacotherapy, 30 (3): 290-303. [PMID:20180612] |